US 7601840
Carboline derivatives useful in the inhibition of angiogenesis
granted A61KA61K31/437A61K31/4745
Quick answer
US patent 7601840 (Carboline derivatives useful in the inhibition of angiogenesis) held by PTC THERAPEUTICS, INC. expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/437, A61K31/4745, A61K31/497, A61K31/506